Back to News
Market Impact: 0.35

Prediction: Nike Stock Set for 25% Rebound After Brutal Year

Corporate EarningsCapital Returns (Dividends / Buybacks)Company FundamentalsAnalyst InsightsRegulation & LegislationConsumer Demand & Retail

Nike’s Q1 FY27 results showed a bright spot, with revenue of $10.97B beating the $10.85B consensus and diluted EPS of $0.72 vs. an estimate of $0.1273, but EPS was boosted by a $986M one-time IEEPA tariff recovery. Management is leaning into its “Win Now” strategy—wholesale rose 4% and North America revenue increased 3%—while gross margin reached 49.2% and the company has an $18B four-year buyback authorization plus a continued dividend growth streak. 24/7 Wall St. reiterated a $51.21 12-month target (24.76% upside) and a BUY rating (90% confidence), though the thesis hinges on Greater China stabilizing and disruptor brand pressure easing.

Analysis

The market is still treating Nike like a structural loser, but the more investable mechanism is margin repair, not top-line heroics. Once a mature brand finishes cleaning up inventory and pushes mix back through wholesale, earnings leverage can re-assert quickly, which is why the stock can rerate even on only modest revenue stabilization. The recent earnings beat matters less than the fact that the balance sheet and buyback capacity give management time to reset the narrative without financial stress.

The second-order winners are wholesale partners and mall/athletic retailers that benefit if Nike re-prioritizes external distribution; the losers are premium athletic peers and digitally native challengers that have been feeding on Nike’s self-inflicted channel weakness. Over the next 1-3 months, the key catalyst is not absolute growth but whether China and NIKE Direct stop deteriorating; if they flatten, shorts lose the ability to extrapolate a straight-line decline. The main risk is that gross margin looks “okay” only because of mix and one-offs while underlying demand stays soft, which would cap any multiple recovery.

Contrarian take: consensus is probably overvaluing the one-time earnings help and undervaluing insider buying plus repurchase support at a depressed valuation. That said, this is still a turnaround, not a clean growth re-acceleration, so the stock can stay range-bound for quarters if execution is uneven. The thesis is falsified if Greater China worsens beyond ~15% declines or if gross margin slips back below the high-40s on the next two reports.

More News